Searches for TeX and B + → J/ψ p TeX π + decays

The results of searches for B0(s)→J/ψ pp¯ and B + → J/ψ p p¯ π+ decays are reported. The analysis is based on a data sample, corresponding to an integrated luminosity of 1.0 fb−1 of pp collisions, collected with the LHCb detector. An excess with 2.8 σ significance is seen for the decay B0s→J/ψ pp¯ and an upper limit on the branching fraction is set at the 90 % confidence level: B(B0s→J/ψ pp¯) < 4.8 × 10−6, which is the first such limit. No significant signals are seen for B 0 → J/ψ p p¯ and B + → J/ψ p p¯ π + decays, for which the corresponding limits are set: B(B0→J/ψ pp¯) < 5.2 × 10−7, which significantly improves the existing limit; and B(B+→J/ψ pp¯π+) < 5.0 × 10−7, which is the first limit on this branching fraction.

Severe pneumonia due to Parachlamydia acanthamoebae following intranasal inoculation: a mice model.

Parachlamydia acanthamoebae is an obligate intracellular bacterium naturally infecting free-living amoebae. The role of this bacterium as an agent of pneumonia is suggested by sero-epidemiological studies and molecular surveys. Furthermore, P. acanthamoebae may escape macrophages microbicidal effectors. Recently, we demonstrated that intratracheal inoculation of P. acanthamoebae induced pneumonia in 100% of infected mice. However, the intratracheal route of infection is not the natural way of infection and we therefore developed an intranasal murine model. Mice inoculated with P. acanthamoebae by intranasal inoculation lost 18% of their weight up to 8 days post-inoculation. All mice presented histological signs of pneumonia at day 2, 4, 7, and 10 post-inoculation, whereas no control mice harboured signs of pneumonia. A 5-fold increase in bacterial load was observed from day 0 to day 4 post-inoculation. Lungs of inoculated mice were positive by Parachlamydia-specific immunohistochemistry 4 days post-inoculation, and P. acanthamoebae were localized within macrophages. Thus, we demonstrated that P. acanthamoebae induce a severe pneumonia in mice. This animal model (i) further supports the role of P. acanthamoebae as an agent of pneumonia, confirming the third Koch postulate, and (ii) identified alveolar macrophages as one of the initial cells where P. acanthamoebae is localized following infection.

Comparison of Four Sections for Analyzing Running Mechanics Alterations During Repeated Treadmill Sprints.

We compared different approaches to analyze running mechanics alterations during repeated treadmill sprints. Thirteen active male athletes performed five 5-second sprints with 25 seconds of recovery on an instrumented treadmill. This approach allowed continuous measurement of running kinetics/kinematics and calculation of vertical and leg stiffness variables that were subsequently averaged over 3 distinct sections of the 5-second sprint (steps 2-5, 7-10, and 12-15) and for all steps (steps 2-15). Independently from the analyzed section, propulsive power and step frequency decreased with fatigue, while contact time and step length increased (P < .05). Except for step frequency, all mechanical variables varied (P < .05) across sprint sections. The only parameters that highly depend on running velocity (propulsive power and vertical stiffness) showed a significant interaction (P < .05) between the analyzed sections, with smaller magnitude of fatigue-induced change observed for steps 2-5. Considering all steps or only a few steps during early, middle, or late phases of 5-second sprints provides similar mechanical outcomes during repeated treadmill sprinting, although acceleration induces noticeable differences between the sections studied. Furthermore, quantifying mechanical alterations from the early acceleration phase may not be readily detectable, and is not recommended.

Prevalence and clinical outcomes for patients with MET protein expression in patients with non-small cell lung cancer in Europe: Results from the European Thoracic Oncology Platform Lungscape Project.

Aim The reported prevalence of MET overexpression varies from 25-55% in non-small cell lung cancer (NSCLC) and clinical correlations are emerging slowly. In a well-defined NSCLC cohort of the Lungscape program, we explore the epidemiology, the natural history of IHC MET positivity and its association to OS, RFS and TTR. Methods Resected stage I-III NSCLC identified based on the quality of clinical data and FFPE tissue availability were assessed for MET expression using immunohistochemistry (IHC) on TMAs (CONFIRM anti total c-MET assay, clone SP44, Ventana BenchMark platform). All cases were analysed at participating pathology laboratories using the same protocol, after passing an external quality assurance program. MET positive status is defined as ≥ 50% of tumor cells staining with 2+ or 3+ intensity. Results A total of 2709 cases are included in the iBiobank and will be analysed. IHC MET expression is currently available for 1552 patients, with positive MET IHC staining in 380 cases [24.5%; IHC 3+ in 157 cases (41.3%) and 2+ in 223 cases (58.7%)]. The cohort of 1552 patients includes 48.2%, 44.7% and 4.4% cases of adenocarcinoma, squamous and large cell histologies, respectively. IHC MET status was independent of stage, age and smoking history. Significant differences in MET positivity were associated with gender (32% vs. 21% for female vs. male, p < 0.001), with performance status (25% vs. 18% for 0 vs. 1-3, p = 0.006), and histology (34%, 14% and 24% for adenocarcinoma, squamous and large cell carcinoma, p < 0.001). IHC MET positivity was independent of the IHC ALK status (p = 0.08). At last FU, 52% of patients were still alive, with a median FU of 4.8 yrs. No association of IHC MET was found with OS, RFS or TTR. Conclusions The preliminary results for this large multicentre European cohort describe a prevalence of MET overexpression that seems lower than previous observations in NSCLC, such as reported for the OAM4971g trial, suggesting potential biological differences between surgically resected and metastatic disease. Analysis for the full cohort is ongoing and results will be presented. Disclosure L. Bubendorf: Disclosures: Stock ownership: Roche Advisory boards: Roche, Pfizer Research support: Roche; K. Schulze: Full time employee of Roche; A. Das-Gupta: I am a full time employee of Roche. All other authors have declared no conflicts of interest.

Barcelonassa elämänlaatua etsimässä

International Association of Gerontologyn (IAG) 5. Euroopan alueen gerontologian konferenssi 2.-5.7.2003

Fat oxidation over a range of exercise intensities: fitness versus fatness.

Maximal fat oxidation (MFO), as well as the exercise intensity at which it occurs (Fatmax), have been reported as lower in sedentary overweight individuals but have not been studied in trained overweight individuals. The aim of this study was to compare Fatmax and MFO in lean and overweight recreationally trained males matched for cardiorespiratory fitness (CRF) and to study the relationships between these variables, anthropometric characteristics, and CRF. Twelve recreationally trained overweight (high fatness (HiFat) group, 30.0% ± 5.3% body fat) and 12 lean males (low fatness (LoFat), 17.2% ± 5.7% body fat) matched for CRF (maximal oxygen consumption (V̇O2max) 39.0 ± 5.5 vs. 41.4 ± 7.6 mL·kg(-1)·min(-1), p = 0.31) and age (p = 0.93) performed a graded exercise test on a cycle ergometer. V̇O2max and fat and carbohydrate oxidation rates were determined using indirect calorimetry; Fatmax and MFO were determined with a mathematical model (SIN); and % body fat was assessed by air displacement plethysmography. MFO (0.38 ± 0.19 vs. 0.42 ± 0.16 g·min(-1), p = 0.58), Fatmax (46.7% ± 8.6% vs. 45.4% ± 7.2% V̇O2max, p = 0.71), and fat oxidation rates over a wide range of exercise intensities were not significantly different (p > 0.05) between HiFat and LoFat groups. In the overall cohort (n = 24), MFO and Fatmax were correlated with V̇O2max (r = 0.46, p = 0.02; r = 0.61, p = 0.002) but not with % body fat or body mass index (p > 0.05). Fat oxidation during exercise was similar in recreationally trained overweight and lean males matched for CRF. Consistently, substrate oxidation rates during exercise were not related to adiposity (% body fat) but were related to CRF. The benefits of high CRF independent of body weight and % body fat should be further highlighted in the management of obesity.

Aramäisch

Table des matières: 1. Einführung 2. Sprachstufen des Aramäischen 2.1. Die frühesten Zeugnisse: Altaramäisch (9.-8. Jh. v.d.Z.) 2.2. Verwendung als lingua franca: Reichsaramäisch (ca. 700-200 v.d.Z.) 2.2.1. Inschriften und Dokumente aus neuassyrischer und neubabylonischer Zeit 2.2.2. Inschriften und Dokumente aus persischer und früh-nachpersischer Zeit 2.2.3. Kennzeichen des Reichsaramäischen 2.3. Lokale Fortentwicklungen: Mittelaramäisch (ca. 200 v.d.Z. - ca. 250 n.d.Z.) 2.4. Spätaramäisch (ca. 250-1200 n.d.Z.) 2.5. Neuaramäisch 3. Aramäisch im Tenach 3.1. Aramaismen 3.1.1. Gezielt verwendete Aramaismen 3.1.2. Aramaismen als Folge der fortwährenden Beeinflussung des Hebräischen durch das Aramäische 3.2. Die aramäischen Passagen in Esra, Daniel, Jeremia 3.2.1. Esr 4,8-6,18; 7,12-26 3.2.2. Daniel 2,4b-7,28 3.2.3. Jeremia 10,11 Literaturverzeichnis 1. Lexikonartikel 2. Textausgaben, Hilfsmittel und spezialisierte Literatur

Physiologie et biomécanique du ski-alpinisme

Introduction: Ski mountaineering is an increasingly popular winter sport and leisure activity. Elite athletes practice this sport with a high level of professionalism, but so far little scientific evidence was available to support their approach. The main aim of this work was to develop a specific knowledge about ski mountaineering, allowing providing specific recommendations for the practice. Methods: First we investigated energy cost (EC) and vertical energy cost (ECv). These two parameters were estimated with oxygen uptake, at different gradients (7 to 33%) and different speeds (2 to 7 km·∙h-­‐1) on treadmill with roller skis and on snow with ski mountaineering gear. Then we assessed energy expenditure (EE) during a long duration ski mountaineering event by measuring heart rate and altitude all along the race and associating them with an EE. The EE was compared with the energy intake during the race. Hydration level was estimated by comparing body weight immediately before and after the race. The energy intake during the 4 days preceding the race was estimated with food diaries and compared with the guidelines. Results/discussion: EC and ECv of ski mountaineering were very high and varied with gradient and speed. ECv decreased between 7 and 33% and with increasing speed at steep gradients. For a 5 h 51 ± 53 min race, the mean EE was 22.6 ± 2.6 MJ. The energy intake covered 20 ± 7% of the EE and was about 14% lower than the recommendations. No significant dehydration was observed. For the longest (53 km) race, we can extrapolate the EE as about 40 MJ. Before the race the energy intake and especially the carbohydrate intake were far under the guidelines (83 ± 17% and 46 ± 13% of the recommendations). Conclusions: EC and EE of ski mountaineering are very high. To minimize the EE to reach the top of a mountain and optimize the performance, the skier should choose a steep gradient and combine this steep gradient with a fast speed. The CHO intake should be increased during but, also before the race while the fluid intake seemed to be adequate. -- Introduction : Le ski-­‐alpinisme est un sport d'hiver qui s'est particulièrement développé durant les dernières décennies : de plus en plus de personnes pratiquent cette activité dans un cadre de loisirs et de plus en plus d'athlètes d'élite prennent part à des compétitions qu'ils préparent avec un haut degré de professionnalisme. Cependant, les connaissances scientifiques restent limitées et les athlètes ne disposent pas de recommandations précises et spécifiques. Le but principal de ce travail est donc de développer un savoir spécifique sur le ski-­‐alpinisme, ce qui devrait permettre d'établir des recommandations pour la pratique. Méthode : Le coût énergétique (CE) et le coût énergétique vertical (CEv) du ski-­‐alpinisme ont été calculés en mesurant la consommation d'oxygène à différentes pentes (7 à 33%) et vitesses (2 à 6.8 km·∙h-­‐1) sur tapis roulant avec des skis à roulettes et sur le terrain avec des skis de randonnée. Ensuite, la dépense énergétique (DE) d'une course de ski-­‐alpinisme de longue durée a été évaluée en mesurant la fréquence cardiaque et l'altitude en continu. La DE a été comparée à l'énergie consommée par les ravitaillements. Des carnets alimentaires ont permis d'estimer la consommation d'énergie (boissons et nourriture) pendant les 4 jours précédant la course. Résultats/discussion : Le CE du ski-­‐alpinisme est très élevé. Le CEv diminue entre 2 et 6 km·∙h-­‐1 et entre 7 et 33%. Pour une course de 5 h 51 ± 53 min (26 km), la DE était de 22.6 ± 2.6 MJ, alors que, pour le grand parcours de la Patrouille des Glaciers (53 km), elle serait d'environ 40 MJ. La consommation d'énergie, pendant le parcours de 26 km, couvrait 20 ± 7% de la DE et était inférieure de 14% aux recommandations, alors qu'aucune déshydratation significative n'était constatée. Les jours précédant la course, la consommation d'énergie et surtout d'hydrates de carbone était bien inférieure aux quantités recommandées (83 ± 17% et 46 ± 13% des recommandations). Conclusion : Le CE et la DE étaient très élevés. Pour minimiser la dépense lors d'une ascension, il faut combiner pente et vitesse élevées. La consommation d'hydrates de carbone devrait être massivement augmentée avant et pendant la course, alors que l'hydratation semble adéquate.

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age-standardised adult prevalence of diabetes at its 2010 levels. We aimed to estimate worldwide trends in diabetes, how likely it is for countries to achieve the global target, and how changes in prevalence, together with population growth and ageing, are affecting the number of adults with diabetes. We pooled data from population-based studies that had collected data on diabetes through measurement of its biomarkers. We used a Bayesian hierarchical model to estimate trends in diabetes prevalence-defined as fasting plasma glucose of 7.0 mmol/L or higher, or history of diagnosis with diabetes, or use of insulin or oral hypoglycaemic drugs-in 200 countries and territories in 21 regions, by sex and from 1980 to 2014. We also calculated the posterior probability of meeting the global diabetes target if post-2000 trends continue. We used data from 751 studies including 4,372,000 adults from 146 of the 200 countries we make estimates for. Global age-standardised diabetes prevalence increased from 4.3% (95% credible interval 2.4-7.0) in 1980 to 9.0% (7.2-11.1) in 2014 in men, and from 5.0% (2.9-7.9) to 7.9% (6.4-9.7) in women. The number of adults with diabetes in the world increased from 108 million in 1980 to 422 million in 2014 (28.5% due to the rise in prevalence, 39.7% due to population growth and ageing, and 31.8% due to interaction of these two factors). Age-standardised adult diabetes prevalence in 2014 was lowest in northwestern Europe, and highest in Polynesia and Micronesia, at nearly 25%, followed by Melanesia and the Middle East and north Africa. Between 1980 and 2014 there was little change in age-standardised diabetes prevalence in adult women in continental western Europe, although crude prevalence rose because of ageing of the population. By contrast, age-standardised adult prevalence rose by 15 percentage points in men and women in Polynesia and Micronesia. In 2014, American Samoa had the highest national prevalence of diabetes (>30% in both sexes), with age-standardised adult prevalence also higher than 25% in some other islands in Polynesia and Micronesia. If post-2000 trends continue, the probability of meeting the global target of halting the rise in the prevalence of diabetes by 2025 at the 2010 level worldwide is lower than 1% for men and is 1% for women. Only nine countries for men and 29 countries for women, mostly in western Europe, have a 50% or higher probability of meeting the global target. Since 1980, age-standardised diabetes prevalence in adults has increased, or at best remained unchanged, in every country. Together with population growth and ageing, this rise has led to a near quadrupling of the number of adults with diabetes worldwide. The burden of diabetes, both in terms of prevalence and number of adults affected, has increased faster in low-income and middle-income countries than in high-income countries. Wellcome Trust.

Seroprevalence of Coxiella burnetii and Brucella abortus among pregnant women.

Coxiella burnetii and Brucella abortus are two intracellular bacteria implicated in zoonotic miscarriage. In the present study, C. burnetii and B. abortus seroprevalence was compared among women from London with and without miscarriage. Coxiella burnetii seroprevalence was high (4.6%, 95% CI 2.8-7.1) despite the rare apparent exposure of this urban population. Only two patients exhibited anti-B. abortus antibodies. As a result of the risk of chronic Q fever with endocarditis and/or hepatitis, the mode of Coxiella burnetii infection in this population merits further investigation.

Reatividade Relativa em Solvólise Nucleofílica de Cloretos de Arilsulfenila, Arilcarbonila, Arilsulfonila, Arilmetila e de Arila

The experimental results for the 2-propanolysis of benzoyl, benzyl, benzene sulphenyl and benzene sulphonyl chlorides obtained by conductimetric technique were compared with estimates for chlorobenzene which is extremely unreactive as an electrophile. We thus obtained the following reactivity sequence: PhSCl>PhCOCl>PhSO2Cl>PhCH2 Cl>PhCl with rate-coefficiente ratios (in the same order): 9.5 x 10(4) : 1: 7.14 x 10-2 : 4.7 x 10-3 : about 10-26. We have discussed these results in specific terms and with the aid of general conclusions which stem from our own classification of electrophiles.

Investigação de Er3+ nos dois sítios cristalográficos de Gd2SiO5 através da fotoluminescência resolvida no tempo

Gadolinium oxyortho-silicate, Gd2SiO5, presents a monoclinic structure with two crystallographic sites in which Gd3+ ions are equally distributed with coordination numbers CN, 7 and 9, respectively. By doping this host with Er3+ it is possible to distinguish and attribute the two sites by means of lifetime determination of the 4S3/2 state, (in this case, Er3+ substitutes Gd3+ ions). Samples doped with 0.1 and 5.0% molar Er3+ were prepared by solid state reaction and characterized by X-ray Diffractometry, Vibrational and Electronic Absorption Spectroscopies, and Time Resolved Photoluminescence. Based on the experimental results, it is possible to verify that, for the 5,0% doped sample, the lifetime value of the 4S3/2 state of the erbium ion inserted in site 1, (CN = 9), is 2.7 ± 0.1 mus, and for the one inserted in site 2, (CN = 7), it is 1.5 ± 0.1 mus.

Symphonie No 1

Melartinin käsikirjoitusluettelon tunnus Mel 2:6-7 (ks. http://lib.siba.fi/fi/kokoelmat/kasikirjoitusarkisto/melartin_erkki/). Mukana myös osien 3 ja 4 muokatut versiot sekä 1. osan 16 ensimmäistä sivua päiväämättömänä versiona.

Estudo eletroquímico do azul de metileno adsorvido sobre sílica gel quimicamente modificada com óxido de nióbio

Methylene blue (AM) was immobilised on surface of the silica gel modified with niobium oxide. This material was incorporated in a carbon paste electrode, which showed a redox couple in a potential of E= -113 mV vs SCE in KCl solution at pH 7.0. The formal potential, in 0.5 mol L-1 KCl at pH 7.0, shifted about 290 mV towards more positive values compared to those observed for AM solubilized in aqueous solution. The dependence on the formal potential with solution pH between 2 and 7 was much lower than those observed for AM solubilized in aqueous solution.

Determinação enzimática de dopamina em formulações farmacêuticas utilizando sistema de análise por injeção em fluxo com extrato bruto de abacate (Persea americana)

In this work, a spectrophotometric flow injection analysis system using a crude extract of avocado (Persea americana) as a source of polyphenol oxidase to dopamine determination was developed. The substrates and enzyme concentrations from 2.4x10-7 to 5.3x10-4 mol L-1 and 28 to 332 units mL-1 were evaluated, respectively. In addition, the FIA parameters such as sample loop (50 to 500 µL), flow rate (1.4 to 4.3 mL min-1) and reactor length (100 to 500 cm) were also evaluated in a 0.1 mol L-1 phosphate buffer solution (pH 7.0). Dopamine solution concentrations were determined using 277 units mL-1 enzyme solution, 400 mL enzyme loop, 375 µL sample loop, 2.2 mL min-1 flow rate and a reactor of 350 cm. The analytical curve showed a linearity from 5.3x10-5 to 5.3x10-4 mol L-1 dopamine with a detection limit of 1.3x10-5 mol L-1. The analytical frequency was 46 h-1 and the RSD lower than 0.5% for 5.3x10-4 mol L-1 dopamine solution (n=10). A paired t-test showed that all results obtained for dopamine in commercial formulations using the proposed flow injection procedure and a spectrophotometric procedure agree at the 95% confidence level.